Experimental validation for quantitative protein network models

Current Opinion in Biotechnology

Volumn 19, Issue 1, 2008, Pages 41-49

  Nishizuka, Satoshi ^a,b,c   Spurrier, Brett ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CHEMICAL ANALYSIS; MICROARRAYS;

CELLULAR RESPONSES; PROTEIN NETWORKS;

PROTEINS;

PROTEIN;

CELL LYSATE; EXPERIMENTAL STUDY; HUMAN; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; THEORETICAL STUDY; VALIDATION STUDY;

BIOTECHNOLOGY; HUMANS; MODELS, BIOLOGICAL; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS;

EID: 39149112497     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2007.11.007     Document Type: Review

References (48)

1. Ge H., Walhout A.J., and Vidal M. Integrating 'omic' information: a bridge between genomics and systems biology. Trends Genet 19 (2003) 551-560
2. Greenbaum D., Luscombe N.M., Jansen R., Qian J., and Gerstein M. Interrelating different types of genomic data, from proteome to secretome: 'oming in on function. Genome Res 11 (2001) 1463-1468
3. Weinstein J.N. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr Opin Pharmacol 2 (2002) 361-365
4. Albeck J.G., MacBeath G., White F.M., Sorger P.K., Lauffenburger D.A., and Gaudet S. Collecting and organizing systematic sets of protein data. Nat Rev Mol Cell Biol 7 (2006) 803-812. A number of limitations should be recognized in proteomic data collection in a systems biology context. However, using multidimensional and multiplex data acquisition from different methods will make a system-level interpretation of biological systems possible by compensating the advantages and disadvantages of each technique. It is also important to relate experimental data while theoretical models are being built up.
5. Gulmann C., Espina V., Petricoin III E., Longo D.L., Santi M., Knutsen T., Raffeld M., Jaffe E.S., Liotta L.A., and Feldman A.L. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 11 (2005) 5847-5855
6. Herrmann P.C., Gillespie J.W., Charboneau L., Bichsel V.E., Paweletz C.P., Calvert V.S., Kohn E.C., Emmert-Buck M.R., Liotta L.A., and Petricoin III E.F. Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3 (2003) 1801-1810
7. Jiang R., Mircean C., Shmulevich I., Cogdell D., Jia Y., Tabus I., Aldape K., Sawaya R., Bruner J.M., Fuller G.N., et al. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics 6 (2006) 2964-2971
8. Paweletz C.P., Charboneau L., Bichsel V.E., Simone N.L., Chen T., Gillespie J.W., Emmert-Buck M.R., Roth M.J., Petricoin I.E., and Liotta L.A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20 (2001) 1981-1989
9. Petricoin III E.F., Espina V., Araujo R.P., Midura B., Yeung C., Wan X., Eichler G.S., Johann Jr. D.J., Qualman S., Tsokos M., et al. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67 (2007) 3431-3440
10. Posadas E.M., Kwitkowski V., Kotz H.L., Espina V., Minasian L., Tchabo N., Premkumar A., Hussain M.M., Chang R., Steinberg S.M., et al. A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer 110 (2007) 309-317
11. Rudelius M., Pittaluga S., Nishizuka S., Pham T.H., Fend F., Jaffe E.S., Quintanilla-Martinez L., and Raffeld M. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108 (2006) 1668-1676
12. Tibes R., Qiu Y., Lu Y., Hennessy B., Andreeff M., Mills G.B., and Kornblau S.M. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther 5 (2006) 2512-2521
13. Wulfkuhle J.D., Aquino J.A., Calvert V.S., Fishman D.A., Coukos G., Liotta L.A., and Petricoin III E.F. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3 (2003) 2085-2090
14. Chan S.M., Ermann J., Su L., Fathman C.G., and Utz P.J. Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med 10 (2004) 1390-1396
15. Mendes K.N., Nicorici D., Cogdell D., Tabus I., Yli-Harja O., Guerra R., Hamilton S.R., and Zhang W. Analysis of signaling pathways in 90 cancer cell lines by protein lysate array. J Proteome Res 6 (2007) 2753-2767
16. Nishizuka S., Charboneau L., Young L., Major S., Reinhold W.C., Waltham M., Kouros-Mehr H., Bussey K.J., Lee J.K., Espina V., et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 100 (2003) 14229-14234
17. Shankavaram U.T., Reinhold W.C., Nishizuka S., Major S., Morita D., Chary K.K., Reimers M.A., Scherf U., Kahn A., Dolginow D., et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6 (2007) 820-832
18. Winters M.E., Mehta A.I., Petricoin III E.F., Kohn E.C., and Liotta L.A. Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res 65 (2005) 3853-3860
19. Ramalingam S., Honkanen P., Young L., Shimura T., Austin J., Steeg P.S., and Nishizuka S. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer Res 67 (2007) 6247-6252. First introduced the advantage of RPA as experimental reference for theoretical protein network modeling. A set of mathematical models of p53-Mdm2 feedback loop was fine-tuned by referencing experimental data from the p53 wild-type cell line. Subsequently, Mdm2 behavior from the p53 knockout line of the theoretical model was compared with a corresponding p53 knockout model cell line. The similarity of in silico prediction and the experimental data suggests that the mathematical models may carry fundamental information about the feedback loop.
20. Kholodenko B.N. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7 (2006) 165-176. Tempora-spatial dynamics of protein signaling regulates its activities. These are pivotal information when theoretical modeling is considered; however, quantitative kinetic data of a number of protein species has been largely missing. The increasing scale of quantitative and qualitative experimental data will facilitate understanding of the molecular mechanisms that have been constructed by the accumulation of knowledge, and will eliminate unrealistic predictions made without experimental validation.
21. Sauro H.M., and Kholodenko B.N. Quantitative analysis of signaling networks. Prog Biophys Mol Biol 86 (2004) 5-43
22. Di Ventura B., Lemerle C., Michalodimitrakis K., and Serrano L. From in vivo to in silico biology and back. Nature 443 (2006) 527-533. A classic topic, 'simulations of biological systems,' is now possibly confirmed by a large-scale quantitative data set. One of the aims of this paper is to familiarize experimentalists with the multidisciplinary efforts of biologists to complement biological methods with a computational approach. One important perspective is to use perturbation models for elucidating molecular function. It is also interesting to read the 'cultural difference' between experimental and computational biologists.
23. Nishizuka S., Chen S.T., Gwadry F.G., Alexander J., Major S.M., Scherf U., Reinhold W.C., Waltham M., Charboneau L., Young L., et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res 63 (2003) 5243-5250
24. Ferrell Jr. J.E., and Machleder E.M. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280 (1998) 895-898
25. Gonzalez-Garcia I., Sole R.V., and Costa J. Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A 99 (2002) 13085-13089
26. Kringstein A.M., Rossi F.M., Hofmann A., and Blau H.M. Graded transcriptional response to different concentrations of a single transactivator. Proc Natl Acad Sci U S A 95 (1998) 13670-13675
27. Portle S., Causey T.B., Wolf K., Bennett G.N., San K.Y., and Mantzaris N. Cell population heterogeneity in expression of a gene-switching network with fluorescent markers of different half-lives. J Biotechnol 128 (2007) 362-375
28. Tu S.M., Lin S.H., and Logothetis C.J. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol 3 (2002) 508-513
29. Sachs K., Perez O., Pe'er D., Lauffenburger D.A., and Nolan G.P. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308 (2005) 523-529
30. Geva-Zatorsky N., Rosenfeld N., Itzkovitz S., Milo R., Sigal A., Dekel E., Yarnitzky T., Liron Y., Polak P., Lahav G., et al. Oscillations and variability in the p53 system. Mol Syst Biol 2 (2006) 2006.0033
31. Lahav G., Rosenfeld N., Sigal A., Geva-Zatorsky N., Levine A.J., Elowitz M.B., and Alon U. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36 (2004) 147-150
32. Di Carlo D., Aghdam N., and Lee L.P. Single-cell enzyme concentrations, kinetics, and inhibition analysis using high-density hydrodynamic cell isolation arrays. Anal Chem 78 (2006) 4925-4930
33. Nishizuka S. Profiling cancer stem cells using protein array technology. Eur J Cancer 42 (2006) 1273-1282
34. Major S.M., Nishizuka S., Morita D., Rowland R., Sunshine M., Shankavaram U., Washburn F., Asin D., Kouros-Mehr H., Kane D., et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. BMC Bioinformatics 7 (2006) 192
35. Spurrier B., Washburn F., Asin D., Ramalingam S., and Nishizuka S. Antibody screening database for protein kinetic modeling. Proteomics 7 (2007) 3259-3263. Introduced an economical but exhaustive way to screen antibody-sample combinational specificity for better RPA quality control. Two hundred and seventy-nine antibodies, including antiphosphor antibodies, were screened against multiple types of cell lysates from various treatments and time points in terms of production of a single predominant band.
36. Amit I., Citri A., Shay T., Lu Y., Katz M., Zhang F., Tarcic G., Siwak D., Lahad J., Jacob-Hirsch J., et al. A module of negative feedback regulators defines growth factor signaling. Nat Genet 39 (2007) 503-512
37. Haberichter T., Madge B., Christopher R.A., Yoshioka N., Dhiman A., Miller R., Gendelman R., Aksenov S.V., Khalil I.G., and Dowdy S.F. A systems biology dynamical model of mammalian G1 cell cycle progression. Mol Syst Biol 3 (2007) 84
38. Hao N., Behar M., Parnell S.C., Torres M.P., Borchers C.H., Elston T.C., and Dohlman H.G. A systems-biology analysis of feedback inhibition in the Sho1 osmotic-stress-response pathway. Curr Biol 17 (2007) 659-667
39. Lev Bar-Or R., Maya R., Segel L.A., Alon U., Levine A.J., and Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A 97 (2000) 11250-11255
40. Sasagawa S., Ozaki Y., Fujita K., and Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 7 (2005) 365-373
41. Loebke C., Sueltmann H., Schmidt C., Henjes F., Wiemann S., Poustka A., and Korf U. Infrared-based protein detection arrays for quantitative proteomics. Proteomics 7 (2007) 558-564
42. Sevecka M., and MacBeath G. State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling. Nat Methods 3 (2006) 825-831. Toward effective drug target discovery, this paper demonstrated a sophisticated strategy in small-molecule screening evaluated by quantitative protein expression change by RPA. The antibody quality control process is exhaustive and the authors speculated that more antibodies of good performance on RPA can be identified if antibody screening is performed in an earlier stage of their production.
43. Sahin O., Lobke C., Korf U., Appelhans H., Sultmann H., Poustka A., Wiemann S., and Arlt D. Combinatorial RNAi for quantitative protein network analysis. Proc Natl Acad Sci U S A 104 (2007) 6579-6584
44. Hu J., He X., Baggerly K.A., Coombes K.R., Hennessy B.T., and Mills G.B. Nonparametric quantification of protein lysate arrays. Bioinformatics 23 (2007) 1986-1994. This paper clearly pointed out that all dose-response curves from an RPA should be fit using a common parameter (if any), allowing comparison between samples, instead of using a sample-by-sample curve fit approach. The nonparametric approach may maintain issues when the ideal dose-response parametric model does not exist; and potentially reduces unnecessary bias such as by a standard logistic curve fit approach.
45. Mircean C., Shmulevich I., Cogdell D., Choi W., Jia Y., Tabus I., Hamilton S.R., and Zhang W. Robust estimation of protein expression ratios with lysate microarray technology. Bioinformatics 21 (2005) 1935-1942
46. Tabus I., Hategan A., Mircean C., Rissanen J., Shmulevich I., Zhang W., and Astola J. Nonlinear modeling of protein expressions in protein arrays. IEEE Trans Signal Process 54 (2006) 2394-2407. Knowing that dose-response curves from RPA are highly nonlinear and vary from antibody to antibody, this paper introduced a set of algorithms for generating calibration curves on a given RPA. The algorithms are exhaustive and could be powerful when an RPA has a sophisticated design and reasonable noise-elimination process before application of the algorithms.
47. De Lean A., Munson P.J., and Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235 (1978) 97-102
48. Carlisle A.J., Prabhu V.V., Elkahloun A., Hudson J., Trent J.M., Linehan W.M., Williams E.D., Emmert-Buck M.R., Liotta L.A., Munson P.J., et al. Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol Carcinogen 28 (2000) 12-22